Keywords: AstraZeneca, Brilique, Germany, Blood thinner,

Brilique first drug to gain post-AMNOG decision in Germany

Article | 16 December 2011

Print This

The German health assessment body, the Federal Joint Committee (G-BA), has issued its final decision regarding the medical benefit of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in